403 related articles for article (PubMed ID: 19713308)
1. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
Chan KE; Lazarus JM; Thadhani R; Hakim RM
J Am Soc Nephrol; 2009 Oct; 20(10):2223-33. PubMed ID: 19713308
[TBL] [Abstract][Full Text] [Related]
2. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
[TBL] [Abstract][Full Text] [Related]
3. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
5. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
6. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
[TBL] [Abstract][Full Text] [Related]
8. Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.
Yodogawa K; Mii A; Fukui M; Iwasaki YK; Hayashi M; Kaneko T; Miyauchi Y; Tsuruoka S; Shimizu W
Heart Vessels; 2016 Oct; 31(10):1676-80. PubMed ID: 26646256
[TBL] [Abstract][Full Text] [Related]
9. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
10. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
11. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
Genovesi S; Santoro A
J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
[No Abstract] [Full Text] [Related]
12. Warfarin use in hemodialysis patients: what is the risk?
Phelan PJ; O'Kelly P; Holian J; Walshe JJ; Delany C; Slaby J; Winders S; O'Toole D; Magee C; Conlon PJ
Clin Nephrol; 2011 Mar; 75(3):204-11. PubMed ID: 21329630
[TBL] [Abstract][Full Text] [Related]
13. Warfarin Use and Increased Mortality in End-Stage Renal Disease.
Lin MC; Streja E; Soohoo M; Hanna M; Savoj J; Kalantar-Zadeh K; Lau WL
Am J Nephrol; 2017; 46(4):249-256. PubMed ID: 28910806
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
15. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.
Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R
Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622
[TBL] [Abstract][Full Text] [Related]
16. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
[TBL] [Abstract][Full Text] [Related]
17. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
[TBL] [Abstract][Full Text] [Related]
18. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
19. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
20. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]